<DOC>
	<DOCNO>NCT02918032</DOCNO>
	<brief_summary>This study aim understand state onset NLSD ( neutral lipid storage disease ) / TGCV ( triglyceride deposit cardiovasculopathy ) worldwide , background information affect patient , natural history disease , well explore prognostic factor assess efficacy disease-specific treatment .</brief_summary>
	<brief_title>International Registry Study Neutral Lipid Storage Disease ( NLSD ) / Triglyceride Deposit Cardiomyovasculopathy ( TGCV ) Related Diseases</brief_title>
	<detailed_description>Since NLSD rare disease , clinical manifestation clinical course sufficiently clarify . Also , number patient country limit . As , consider difficult fully investigate disease without international collaboration . Therefore , establish International Registry NLSD / TGCV . Also , patient Jordans ' anomaly peripheral polymorphonuclear leukocyte establish subject entry start registry , allow entry patient NLSD due gene mutation ATGL CGI-58 gene . Time Perspective : This study Prospective ( register patient diagnose NLSD / TGCV ) Retrospective ( register medical record previous patient ) .</detailed_description>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Lipidoses</mesh_term>
	<mesh_term>Lipid Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Ichthyosiform Erythroderma , Congenital</mesh_term>
	<criteria>Patients diagnose NLSD / TGCV December31 , 2018</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Jordans anomaly</keyword>
	<keyword>neutral lipid storage disease</keyword>
	<keyword>triglyceride deposit cardiovasculopathy</keyword>
	<keyword>ATGL gene</keyword>
	<keyword>CGI-58 gene</keyword>
	<keyword>primary triglyceride deposit cardiomyovasculopathy ( TGCV )</keyword>
	<keyword>neutral lipid storage disease myopathy ( NLSD-M )</keyword>
</DOC>